Lori Swan, MD
Dermatology · Lafayette, INNPI 1518044601
Payments from drug & device makers
Across 102 payments — averaging $40.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biofrontera Inc.$2K
- Galderma Laboratories, L.p.$290
- Novartis$290
- Almirall LLC$284
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$266
- Sun Pharmaceutical Industries Inc.$253
- plus $1K from 17 others
What the payments were for
- Consulting fees$1,50036%
- Food & beverage$2,67564%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biofrontera Inc. | 3 | $1,552 |
| Galderma Laboratories, L.p. | 12 | $290 |
| Novartis | 3 | $290 |
| Almirall LLC | 12 | $284 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $266 |
| Sun Pharmaceutical Industries Inc. | 15 | $253 |
| AbbVie(2 entities) | 5 | $217 |
| Amgen | 6 | $167 |
| E.r. Squibb & Sons, L.L.C. | 7 | $160 |
| Johnson & Johnson | 4 | $111 |
| Merz North America, Inc. | 3 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Revance Therapeutics, Inc. | 1 | $74 |
| Mayne Pharma Commercial LLC | 3 | $69 |
| Genentech USA, Inc. | 3 | $61 |
| Pfizer | 4 | $53 |
| Aclaris Therapeutics, Inc. | 3 | $38 |
| Dermavant Sciences, Inc. | 2 | $30 |
| VYNE Pharmaceuticals Inc. | 1 | $24 |
| Dermira, Inc. | 1 | $20 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $19 |
| Incyte Corporation | 1 | $12 |
| Bristol Myers Squibb | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMELUZ$1,500
- BF-RhodoLED$1,500
- XEPI$1,500
- DUOBRII$139
- COSENTYX$123
How this compares
$4,175 in reported general payments places this provider in the 45th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 41 | $2,020 |
| ValacyclovirValacyclovir Hcl | 32 | $1,136 |
| Metronidazole | 14 | $737 |
| Fluocinonide | 13 | $408 |
| Imiquimod | 14 | $305 |
| Mometasone Furoate | 26 | $297 |
| Ketoconazole | 21 | $290 |
| Triamcinolone Acetonide | 18 | $45 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lafayette
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Holly Hake HarrisSouth Bend$3.4M
- Megan LandisCorydon$2.8M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
- Vassilios DimitropoulosMichigan City$1.8M
- Christopher ObeimeIndianapolis$907K
- Megan VissingNew Albany$884K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.